Arthritis Drug Restores 100% of Hair in Some Patients With Severe Alopecia in Global Trial For decades, alopecia areata has ravaged the lives of millions worldwide.
This autoimmune disease strips its victims of their hair and leaves them feeling isolated and vulnerable. However, a recent global trial using upadacitinib has yielded astonishing results.
The study, published in JAMA Dermatology last month, involved patients from the US, Europe, and China who had suffered severe hair loss due to alopecia areata.